Novel GLP-1 Pill for Obesity Passes Phase III Test

By News Health
4 hours Ago

(MedPage Today) — An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial.
At week 72, orforglipron at multiple doses proved superior to placebo…

Source link : https://www.medpagetoday.com/meetingcoverage/easd/117495

Author :

Publish date : 2025-09-16 22:01:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

FDA Seeks To Abandon Expert Reviews of New Drugs

Prior Authorization Continues to Bedevil Congress

Abortion Advocates Say Social Platforms Are Removing Posts in Apparent Overreach

Substantial Number of People Ditch Wegovy Within a Year

Consider Anal Cancer Screening in Some Older Women, Study Says

CPAP Use Tied to Reduced Mortality in T2D and Sleep Apnea